These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3544969)

  • 1. Salvage of ischemic myocardium by CLS 2210 in the dog: a preliminary double-blind study.
    Szlavy L; Repa I; Szabo Z; de Courten A; Hachen HJ
    Angiology; 1987 Jan; 38(1 Pt 2):85-91. PubMed ID: 3544969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of a lymphagogue, CLS 2210, on regional cardiac lymphatics and the electrocardiogram after coronary artery occlusion in the dog.
    Szlavy L; Repa I; De Courten A
    Lymphology; 1986 Mar; 19(1):15-20. PubMed ID: 3755203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early disappearance of lymphatics draining ischemic myocardium in the dog.
    Szlavy L; Koster K; de Courten A; Hollenberg NK
    Angiology; 1987 Jan; 38(1 Pt 2):73-84. PubMed ID: 3813124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLS 2210, hyaluronidase and the cardiac lymphatic system.
    Szlavy L; Kubik S; de Courten A; Hachen HJ; Solti F
    Angiology; 1985 Jul; 36(7):452-7. PubMed ID: 3839639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction treated with two lymphagogues, calcium dobesilate (CLS 2210) and hyaluronidase: a coded, placebo-controlled animal study.
    Repa I; Garnic JD; Hollenberg NK
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):286-91. PubMed ID: 1697385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CLS 2210 (calcium dobesilate) on survival and myocardial infarction size in the rat: influence of dose and duration of treatment.
    Huttl K; Hollenberg NK
    Cardiology; 1992; 80(1):28-33. PubMed ID: 1555213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium dobesilate (CLS 2210) protects the myocardium in early acute myocardial infarction: a preliminary randomized, double-blind, placebo-controlled study of its effects on biochemical markers.
    Szlavy L; Repa I; Lengyel I; Lamboy L
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):89-95. PubMed ID: 1688988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance.
    Ibanez B; Prat-González S; Speidl WS; Vilahur G; Pinero A; Cimmino G; García MJ; Fuster V; Sanz J; Badimon JJ
    Circulation; 2007 Jun; 115(23):2909-16. PubMed ID: 17515460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs.
    Mullane KM; Read N; Salmon JA; Moncada S
    J Pharmacol Exp Ther; 1984 Feb; 228(2):510-22. PubMed ID: 6420544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs.
    Miyataka M; Ishikawa K; Katori R
    Angiology; 1998 May; 49(5):381-90. PubMed ID: 9591530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.
    Maroko PR; Carpenter CB; Chiariello M; Fishbein MC; Radvany P; Knostman JD; Hale SL
    J Clin Invest; 1978 Mar; 61(3):661-70. PubMed ID: 641147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.
    Reimer KA; Jennings RB
    Lab Invest; 1979 Jun; 40(6):633-44. PubMed ID: 449273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study.
    Kopecky SL; Aviles RJ; Bell MR; Lobl JK; Tipping D; Frommell G; Ramsey K; Holland AE; Midei M; Jain A; Kellett M; Gibbons RJ;
    Am Heart J; 2003 Jul; 146(1):146-52. PubMed ID: 12851624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of myocardial infarct size by noncontact mapping.
    Voss F; Steen H; Bauer A; Giannitsis E; Katus HA; Becker R
    Heart Rhythm; 2008 Feb; 5(2):308-14. PubMed ID: 18242560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of coronary artery reperfusion on infarct size in swine.
    Campbell CD; Takanashi Y; Laas J; Meus P; Pick R; Replogle RL
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):288-96. PubMed ID: 7453239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous streptokinase and CLS 2210 (calcium dobesilate) on the biochemical markers of early acute myocardial infarction: a historic comparison with both studies.
    Szlavy L; Repa I; Lengye I; Lamboy L
    Angiology; 1992 Sep; 43(9):741-7. PubMed ID: 1514710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
    Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
    Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hyaluronidase on reducing myocardial infarct size in a baboon model of ischemia-reperfusion injury.
    Premaratne S; Watanabe BI; LaPenna WF; McNamara JJ
    J Surg Res; 1995 Feb; 58(2):205-10. PubMed ID: 7861774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.